National Comprehensive Cancer Network



About NCCN

Bladder/Penile Cancers Panel - Disclosures as of 4/16/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Neeraj Agarwal, MD

Dendreon Corporation;
GlaxoSmithKline

Exelixis Inc.;
Medivation

None

None

2/19/2014

Matthew C. Biagioli, MD, MS

None

None

None

None

10/31/2013

Peter E. Clark, MD

None

Pacific Edge

None

None

1/7/2014

Mary Dwyer, MS

None

None

None

None

3/7/2014

Mario A. Eisenberger, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
agensys;
sanofi-aventis U.S.

Bayer HealthCare

None

Bristol-Myers Squibb Company

10/31/2013

Thomas Flaig, MD

Amgen Inc.;
Dendreon Corporation;
Exelixis Inc.;
Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
BN Immunotherapies;
GTX;
Medivation;
Pfizer Inc.;
sanofi-aventis U.S.

GTX

None

None

12/30/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Richard E. Greenberg, FACS, MD

None

Endo Pharmaceuticals

None

None

3/26/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Harry W. Herr, MD

None

None

None

None

8/28/2012

Maria Ho, PhD

None

None

None

None

8/14/2013

Brant A. Inman, MD, MSc

Dendreon Corporation

None

None

None

11/2/2013

A. Karim Kader, MD, PhD, FRCSC

None

None

None

None

7/17/2013

Deborah A. Kuban, MD

None

None

None

None

12/10/2013

Timothy M. Kuzel, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Alton Pharmaceuticals;
ARgos Therapeutics;
Aveo;
Biovex, Inc/Amgen

Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Elorac;
Prometheus Laboratories;
Pfizer Inc.

None

None

7/3/2013

Subodh M. Lele, MD

None

None

None

None

8/28/2012

Joan S. McClure, MS

None

None

None

None

8/13/2013

Jeff Michalski, MD, MBA

None

None

None

None

8/15/2013

Jeffrey S. Montgomery, MD, MHSA

None

None

None

None

11/1/2013

Lance C. Pagliaro, MD

None

None

None

None

1/4/2013

Sumanta K. Pal, MD

None

Dendreon Corporation;
Novartis Pharmaceuticals Corporation;
Astellas;
Aveo;
Pfizer Inc.

None

GlaxoSmithKline

5/31/2013

Anthony Patterson, MD

None

None

None

None

11/20/2013

Elizabeth R. Plimack, MD, MS

Bristol-Myers Squibb Company;
Dendreon Corporation;
GlaxoSmithKline;
Merck & Co., Inc.;
Acceleron

Dendreon Corporation;
GlaxoSmithKline;
Astellas

None

None

8/3/2013

Kamal S. Pohar, MD

None

None

None

None

11/12/2013

Michael P. Porter, MD, MS

None

None

None

None

4/29/2013

Jerome Paul Richie, MD

None

None

None

None

4/29/2013

Wade Jeffers Sexton, MD

Endo Pharmaceuticals

ENDO Pharmaceuticals;
Endo Pharmaceuticals

None

None

1/8/2014

William U. Shipley, MD, FACR

None

None

Pfizer Inc.

None

7/3/2013

Eric J. Small, MD

None

None

None

None

1/9/2014

Guru Sonpavde, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
sanofi-aventis U.S.

GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
sanofi-aventis U.S.

None

None

12/19/2013

Philippe E. Spiess, MD

None

None

None

None

4/29/2013

Sarika Trikha

None

None

None

None

8/13/2013

Donald L. Trump, MD

None

None

None

None

6/4/2013

Jonathan Tward, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

8/3/2012

Geoffrey Wile, MD

None

None

None

None

10/31/2013

Timothy G. Wilson, MD

None

None

None

None

7/31/2013